Oncomfort, based in Wavre near Brussels and founded in 2017 by Diane Jooris, Gérald de Patoul, Mario Huyghe and Julien Tesse, develops Digital Sedation™ — therapeutic virtual reality sessions to relieve pain and anxiety. Its core product is the Sedakit™ for Digital Sedation™, launched in Benelux and France in June 2019. The solution has been used across anesthesia, oncology, interventional radiology, cardiology and pediatrics, treating over 30,000 patients. The company completed a €10m Series A funding round to support development of its digital therapy solutions and accelerate international expansion. The round was co-led by Debiopharm and Crédit Mutuel Innovation, with continuing support from Wallonia Innovation and Growth (W.IN.G) and existing investors. Both institutional investors will join Oncomfort’s newly composed Board of Directors.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2020